What has felt like years in the making has finally arrived: a once-weekly insulin. This long-acting (basal) insulin, designed to be injected just once per week, has the potential to simplify long-term insulin therapy in a meaningful way. At first glance, it may not seem like a major shift. But for individuals taking insulin, and for those supporting them, reducing the burden of daily injections can make a real difference in self-care routines, "adherence", and ultimately long-term health outcomes. So what does this mean for you and your patients? Who might be a good fit, and how should you counsel…